Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters











Database
Language
Publication year range
1.
J Physiol Sci ; 68(4): 425-430, 2018 Jul.
Article in English | MEDLINE | ID: mdl-28508339

ABSTRACT

Central adenosine A1-receptor (A1AR)-mediated signals play a role in the induction of hibernation. We determined whether activation of the central A1AR enables rats to maintain normal sinus rhythm even after their body temperature has decreased to less than 20 °C. Intracerebroventricular injection of an adenosine A1 agonist, N6-cyclohexyladenosine (CHA), followed by cooling decreased the body temperature of rats to less than 20 °C. Normal sinus rhythm was fundamentally maintained during the extreme hypothermia. In contrast, forced induction of hypothermia by cooling anesthetized rats caused cardiac arrest. Additional administration of pentobarbital to rats in which hypothermia was induced by CHA also caused cardiac arrest, suggesting that the operation of some beneficial mechanisms that are not activated under anesthesia may be essential to keep heart beat under the hypothermia. These results suggest that central A1AR-mediated signals in the absence of anesthetics would provide an appropriate condition for maintaining normal sinus rhythm during extreme hypothermia.


Subject(s)
Adenosine A1 Receptor Agonists/pharmacology , Adenosine/analogs & derivatives , Body Temperature/drug effects , Hibernation/drug effects , Hypothermia, Induced/methods , Adenosine/pharmacology , Animals , Male , Rats , Rats, Sprague-Dawley
2.
J Physiol Sci ; 68(3): 243-251, 2018 May.
Article in English | MEDLINE | ID: mdl-28124286

ABSTRACT

Somatostatin and its receptors are expressed in the spinal cord, but the functional roles of the peptide remain unknown. In this study, we examined the colokinetic effect of somatostatin in the spinal defecation center in anesthetized rats. Intrathecal application of somatostatin into the lumbo-sacral cord caused propulsive contractions of the colorectum. However, somatostatin administered intravenously or intrathecally to the thoracic cord failed to enhance colorectal motility. Transection of the thoracic cord had no significant impact on the colokinetic action of somatostatin. The enhancement of colorectal motility by intrathecal administration of somatostatin was abolished by severing the pelvic nerves. Our results demonstrate that somatostatin acting on the spinal defecation center causes propulsive motility of the colorectum in rats. Considering that somatostatin is involved in nociceptive signal transmission in the spinal cord, our results provide a rational explanation for the concurrent appearance of chronic abdominal pain and colonic motility disorders in IBS patients.


Subject(s)
Defecation/drug effects , Somatostatin/pharmacology , Spinal Cord/drug effects , Animals , Colon/drug effects , Gastrointestinal Motility/drug effects , Injections, Spinal/methods , Male , Rats , Rats, Sprague-Dawley
3.
J Physiol ; 594(15): 4339-50, 2016 08 01.
Article in English | MEDLINE | ID: mdl-26999074

ABSTRACT

KEY POINTS: The pathophysiological roles of the CNS in bowel dysfunction in patients with irritable bowel syndrome and Parkinson's disease remain obscure. In the present study, we demonstrate that dopamine in the lumbosacral defaecation centre causes strong propulsive motility of the colorectum. The effect of dopamine is a result of activation of sacral parasympathetic preganglionic neurons via D2-like dopamine receptors. Considering that dopamine is a neurotransmitter of descending pain inhibitory pathways, our results highlight the novel concept that descending pain inhibitory pathways control not only pain, but also the defaecation reflex. In addition, severe constipation in patients with Parkinson's disease can be explained by reduced parasympathetic outflow as a result of a loss of the effect of dopaminergic neurons. ABSTRACT: We have recently demonstrated that intrathecally injected noradrenaline caused propulsive contractions of the colorectum. We hypothesized that descending pain inhibitory pathways control not only pain, but also the defaecation reflex. Because dopamine is one of the major neurotransmitters of descending pain inhibitory pathways in the spinal cord, we examined the effects of the intrathecal application of dopamine to the spinal defaecation centre on colorectal motility. Colorectal intraluminal pressure and expelled volume were recorded in vivo in anaesthetized rats. Slice patch clamp and immunohistochemistry were used to confirm the existence of dopamine-sensitive neurons in the sacral parasympathetic nuclei. Intrathecal application of dopamine into the L6-S1 spinal cord, where the lumbosacral defaecation centre is located, caused propulsive contractions of the colorectum. Inactivation of spinal neurons using TTX blocked the effect of dopamine. Although thoracic spinal transection had no effect on the enhancement of colorectal motility by intrathecal dopamine, the severing of the pelvic nerves abolished the enhanced motility. Pharmacological experiments revealed that the effect of dopamine is mediated primarily by D2-like dopamine receptors. Neurons labelled with retrograde dye injected at the colorectum showed an inward current in response to dopamine in slice patch clamp recordings. Furthermore, immunohistochemical analysis revealed that neurons immunoreactive to choline acetyltransferase express D2-like dopamine receptors. Taken together, our findings demonstrate that dopamine activates sacral parasympathetic preganglionic neurons via D2-like dopamine receptors and causes propulsive motility of the colorectum in rats. The present study supports the hypothesis that descending pain inhibitory pathways regulate defaecation reflexes.


Subject(s)
Colon/physiology , Lumbosacral Region/physiology , Receptors, Dopamine D2/physiology , Rectum/physiology , 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/pharmacology , Anesthetics, Local/pharmacology , Animals , Benzazepines/pharmacology , Colon/drug effects , Defecation/physiology , Dopamine/pharmacology , Dopamine Agonists , Dopamine D2 Receptor Antagonists/pharmacology , Dopaminergic Neurons/physiology , Gastrointestinal Motility/physiology , Haloperidol/pharmacology , Injections, Spinal , Lumbosacral Region/innervation , Male , Muscle Contraction/physiology , Quinpirole/pharmacology , Rats, Sprague-Dawley , Receptors, Dopamine D2/agonists , Rectum/drug effects , Spinal Cord/physiology , Spinal Cord/surgery , Tetrodotoxin/pharmacology
4.
J Physiol Sci ; 66(2): 105-11, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26424590

ABSTRACT

To determine whether a capsaicin-sensitive local neural circuit constitutively modulates vagal neuromuscular transmission in the esophageal striated muscle or whether the neural circuit operates in a stimulus-dependent manner, we compared the motility of esophageal preparations isolated from intact rats with those in which capsaicin-sensitive neurons had been destroyed. Electrical stimulation of the vagus nerve trunk evoked contractile responses in the esophagus isolated from a capsaicin-treated rat in a manner similar to those in the esophagus from a control rat. No obvious differences were observed in the inhibitory effects of D-tubocurarine on intact and capsaicin-treated rat esophageal motility. Destruction of the capsaicin-sensitive neurons did not significantly affect latency, time to peak and duration of a vagally evoked twitch-like contraction. These findings indicate that the capsaicin-sensitive neural circuit does not operate constitutively but rather is activated in response to an applied stimulus.


Subject(s)
Capsaicin/pharmacology , Esophagus/physiology , Muscle Contraction/physiology , Muscle, Striated/physiology , Neurons/physiology , Vagus Nerve/physiology , Animals , Electric Stimulation/methods , Esophagus/drug effects , Male , Muscle Contraction/drug effects , Muscle, Striated/drug effects , Neurons/drug effects , Rats , Rats, Sprague-Dawley , Tubocurarine/pharmacology , Vagus Nerve/drug effects
5.
Eur J Pharmacol ; 771: 123-9, 2016 Jan 15.
Article in English | MEDLINE | ID: mdl-26687631

ABSTRACT

Hydrogen sulfide (H2S) is recognized as a gaseous transmitter and has many functions including regulation of gastrointestinal motility. The aim of the present study was to clarify the effects of H2S on the motility of esophageal striated muscle in rats. An isolated segment of the rat esophagus was placed in an organ bath and mechanical responses were recorded using a force transducer. Electrical stimulation of the vagus nerve evoked contractile response in the esophageal segment. The vagally mediated contraction was inhibited by application of an H2S donor. The H2S donor did not affect the contraction induced by electrical field stimulation, which can excite the striated muscle directly, not via vagus nerves. These results show that H2S has an inhibitory effect on esophageal motility not by directly attenuating striated muscle contractility but by blocking vagal motor nerve activity and/or neuromuscular transmissions. The inhibitory actions of H2S were not affected by pretreatment with the transient receptor potential vanniloid-1 blocker, transient receptor potential ankyrin-1 blocker, nitric oxide synthase inhibitor, blockers of potassium channels, and ganglionic blocker. RT-PCR and Western blot analysis revealed the expression of H2S-producing enzymes in esophageal tissue, whereas application of inhibitors of H2S-producing enzymes did not change vagally evoked contractions in the esophageal striated muscle. These findings suggest that H2S, which might be produced in the esophageal tissue endogenously, can regulate the motor activity of esophageal striated muscle via a novel inhibitory neural pathway.


Subject(s)
Esophagus/drug effects , Hydrogen Sulfide/pharmacology , Muscle, Striated/drug effects , Neurotransmitter Agents/pharmacology , Animals , Electric Stimulation , Hydrogen Sulfide/metabolism , Male , Muscle Contraction/drug effects , Neuromuscular Junction/drug effects , Potassium Channels/drug effects , Rats , Rats, Wistar , Synaptic Transmission/drug effects , Transient Receptor Potential Channels/drug effects , Vagus Nerve/drug effects
6.
Biomed Res Int ; 2015: 528523, 2015.
Article in English | MEDLINE | ID: mdl-26550572

ABSTRACT

We investigated the actions of probiotics, Streptococcus faecalis 129 BIO 3B (SF3B), in a trinitrobenzenesulfonic acid- (TNBS-) induced colitis model in rats. After TNBS was administered into the colons of rats for induction of colitis, the rats were divided into two groups: one group was given a control diet and the other group was given a diet containing SF3B for 14 days. There were no apparent differences in body weight, diarrhea period, macroscopic colitis score, and colonic weight/length ratio between the control group and SF3B group, suggesting that induction of colitis was not prevented by SF3B. Next, we investigated whether SF3B-containing diet intake affects the restoration of enteric neurotransmissions being damaged during induction of colitis by TNBS using isolated colonic preparations. Recovery of the nitrergic component was greater in the SF3B group than in the control group. A compensatory appearance of nontachykininergic and noncholinergic excitatory components was less in the SF3B group than in the control group. In conclusion, the present study suggests that SF3B-containing diet intake can partially prevent disruptions of enteric neurotransmissions induced after onset of TNBS-induced colitis, suggesting that SF3B has therapeutic potential.


Subject(s)
Colitis/physiopathology , Colitis/therapy , Enteric Nervous System/physiopathology , Enterococcus faecalis , Gastrointestinal Motility , Probiotics/administration & dosage , Administration, Oral , Animals , Colitis/chemically induced , Enteric Nervous System/microbiology , Male , Rats , Rats, Wistar , Treatment Outcome , Trinitrobenzenesulfonic Acid
7.
Sci Rep ; 5: 12623, 2015 Jul 28.
Article in English | MEDLINE | ID: mdl-26218221

ABSTRACT

Chronic abdominal pain in irritable bowel syndrome (IBS) usually appears in combination with disturbed bowel habits, but the etiological relationship between these symptoms remains unclear. Noradrenaline is a major neurotransmitter controlling pain sensation in the spinal cord. To test the hypothesis that the descending noradrenergic pathway from the brain stem moderates gut motility, we examined effects of intrathecal application of noradrenaline to the spinal defecation center on colorectal motility. Colorectal intraluminal pressure and expelled volume were recorded in vivo in anesthetized rats. Intrathecal application of noradrenaline into the L6-S1 spinal cord, where the lumbosacral defecation center is located, caused propulsive contractions of the colorectum. Inactivation of spinal neurons by tetrodotoxin blocked the effect of noradrenaline. Pharmacological experiments showed that the effect of noradrenaline is mediated primarily by alpha-1 adrenoceptors. The enhancement of colorectal motility by intrathecal noradrenaline was abolished by severing of the pelvic nerves. Our results demonstrate that noradrenaline acting on sacral parasympathetic preganglionic neurons through alpha-1 adrenoceptors causes propulsive motility of the colorectum in rats. Considering that visceral pain activates the descending inhibitory pathways including noradrenergic neurons, our results provide a rational explanation of the concurrent appearance of chronic abdominal pain and colonic motility disorders in IBS patients.


Subject(s)
Colon/drug effects , Defecation/drug effects , Gastrointestinal Motility/drug effects , Norepinephrine/pharmacology , Rectum/drug effects , Spinal Cord/drug effects , Adrenergic alpha-1 Receptor Antagonists/pharmacology , Adrenergic alpha-Agonists/administration & dosage , Adrenergic alpha-Agonists/pharmacology , Anesthetics, Local/pharmacology , Animals , Colon/innervation , Colon/physiology , Defecation/physiology , Gastrointestinal Motility/physiology , Hypogastric Plexus/physiopathology , Hypogastric Plexus/surgery , Injections, Spinal , Kinetics , Lumbosacral Region , Male , Norepinephrine/administration & dosage , Prazosin/pharmacology , Rats, Sprague-Dawley , Rectum/innervation , Rectum/physiology , Spinal Cord/physiology , Tetrodotoxin/pharmacology
8.
Biochem Biophys Res Commun ; 462(4): 322-5, 2015 Jul 10.
Article in English | MEDLINE | ID: mdl-25960293

ABSTRACT

The hearts of hibernating animals are capable of maintaining constant beating despite a decrease in body temperature to less than 10 °C during hibernation, suggesting that the hearts of hibernators are highly tolerant to a cold temperature. In the present study, we examined the expression pattern of cold-inducible RNA-binding protein (CIRP) in the hearts of hibernating hamsters, since CIRP plays important roles in protection of various types of cells against harmful effects of cold temperature. RT-PCR analysis revealed that CIRP mRNA is constitutively expressed in the heart of a non-hibernating euthermic hamster with several different forms probably due to alternative splicing. The short product contained the complete open reading frame for full-length CIRP. On the other hand, the long product had inserted sequences containing a stop codon, suggesting production of a C-terminal deletion isoform of CIRP. In contrast to non-hibernating hamsters, only the short product was amplified in hibernating animals. Induction of artificial hypothermia in non-hibernating hamsters did not completely mimic the splicing patterns observed in hibernating animals, although a partial shift from long form mRNA to short form was observed. Our results indicate that CIRP expression in the hamster heart is regulated at the level of alternative splicing, which would permit a rapid increment of functional CIRP when entering hibernation.


Subject(s)
Alternative Splicing , Hibernation/genetics , Myocardium/metabolism , RNA, Messenger/genetics , RNA-Binding Proteins/metabolism , Animals , Base Sequence , Cricetinae , DNA Primers , Male , Mesocricetus , Polymerase Chain Reaction , RNA-Binding Proteins/genetics
9.
PLoS One ; 6(2): e17092, 2011 Feb 11.
Article in English | MEDLINE | ID: mdl-21347296

ABSTRACT

UNLABELLED: Mesenchymal-epithelial transition events are related to embryonic development, tissue construction, and wound healing. Stem cells are involved in all of these processes, at least in part. However, the direct evidence of mesenchymal-epithelial transition associated with stem cells is unclear. To determine whether mesenchymal-epithelial transition occurs in liver development and/or the differentiation process of hepatic stem cells in vitro, we analyzed a variety of murine liver tissues from embryonic day 11.5 to adults and the colonies derived from hepatic stem/progenitor cells isolated with flow cytometry. The results of gene expression, immunohistochemistry and Western blot showed that as liver develops, the expression of epithelial markers such as Cytokeratin18 and E-cadherin increase, while expression of mesenchymal markers such as vimentin and N-cadherin decreased. On the other hand, in freshly isolated hepatic stem cells, the majority of cells (65.0%) co-express epithelial and mesenchymal markers; this proportion is significantly higher than observed in hematopoietic cells, non-hematopoietic cells and non-stem cell fractions. Likewise, in stem cell-derived colonies cultured over time, upregulation of epithelial genes (Cytokeratin-18 and E-cadherin) occurred simultaneously with downregulation of mesenchymal genes (vimentin and Snail1). Furthermore, in the fetal liver, vimentin-positive cells in the non-hematopoietic fraction had distinct proliferative activity and expressed early the hepatic lineage marker alpha-fetoprotein. CONCLUSION: Hepatic stem cells co-express mesenchymal and epithelial markers; the mesenchymal-epithelial transition occurred in both liver development and differentiation of hepatic stem/progenitor cells in vitro. Besides as a mesenchymal marker, vimentin is a novel indicator for cell proliferative activity and undifferentiated status in liver cells.


Subject(s)
Cell Transdifferentiation , Epithelial Cells/cytology , Liver/cytology , Mesoderm/cytology , Stem Cells/cytology , Animals , Biomarkers/metabolism , Cell Proliferation , Gene Expression Regulation , Liver/growth & development , Liver/metabolism , Mesoderm/metabolism , Mice , Stem Cells/metabolism , Vimentin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL